Active Pharmaceutical Ingredients (APIs)

Centroflora Buys Boehringer Phytochemical API Portfolio

Giving Pharma a Boost

Opportunities Through Biotechnology

Good Manufacturing Practices

Evolution of a Dynamic Healthcare Market

Essential Ingredients

International Drugmakers Meet Challenges

GDUFA’s Impact on the API Industry – an Update

AMRI acquires Cedarburg Pharmaceuticals

Duloxetine: Refining its Chemical Synthesis with Biocatalysis

Pharma In Africa

ICIG is Looking to Expand its Two Major Platforms

U.S. API Manufacturing and Sustainability

PCRAMS is a Booming Business

Outsourcing Biopharmaceutical Manufacturing

Double Risk with an Upgrade

Sourcing from India and China

A Shaky Platform?

Ashland’s Jeff Wolff on the Importance of Innovation

Dottikon Celebrates 100 Years of Transformation

Aesica Unveils New Manufacturing Facility Investing £30 Million

'A Unique Moment'

The Epicenter of the U.S. Pharma Industry

Saltigo: 'Working Proactively With Trends'

Adaptability — A lot has happened in the world of custom manufacturing since Saltigo was carved out of Lanxess' fine chemicals business in 2006.

Value Over Price

Swiss Visionary

The Art of Adding Value

Enzymes as a Catalytic All Rounder

Pharma in India: Responding to Market Dynamics

GDUFA’s Impact on the API Industry

Smithfield’s China Deal Spurs Heparin Heart Drug Safety Concerns

Buyer Beware, Patient Beware

CordenPharma Expands with ICIG Acquisition of Farchemia

Almac, DSM Collaboration Agreement in Biocatalysis Continues with Success

Cedarburg Hauser Adds Controlled Substance Capabilities at Denver Site